We Can Stop Melanoma
At DermTech, we believe we can help end deaths from melanoma in the near future. And we are working with patients, doctors, and other healthcare professionals to bring that promise to life.
We believe this because we have the tools to make it happen. The most effective way to eliminate melanoma deaths is to catch the disease early, and the DermTech Melanoma Test rules out early-stage melanoma correctly over 99% of the time. With a test that can be easily and quickly performed at your doctor’s office, or remotely under your doctor’s supervision. Our goal is to turn this belief into reality. And make melanoma a disease of the past.
“Someone in my life had a delayed melanoma diagnosis and ultimately succumbed to the disease — a disease that, as an M.D., I know is very treatable when caught early. I saw an opportunity to create a better approach to melanoma detection and potentially save lives.”
— John Dobak, M.D.
President and CEO of DermTech
Meet the team that is defining the new era of precision dermatology with innovation, entrepreneurship, passion, and personal experience.
Meet Our Leaders
Meet Our Boards
Our Board of Directors
Our Board of Directors has diverse experience in biotechnology, diagnostics, therapeutics, medical and other industries, bringing decades of experience to the team.
Our Scientific Advisory Board
Our Scientific Advisory Board brings decades of experience in dermatology, skin cancer, genomics, and biotech innovation to help us redefine the way we test and treat skin cancer.
Our Board of Directors
Our Board of Directors has diverse experience in biotechnology, diagnostics, therapeutics, medical and other industries, bringing decades of experience to the team.
Our Scientific Advisory Board
Our Scientific Advisory Board brings decades of experience in dermatology, skin cancer, genomics, and biotech innovation to help us redefine the way we test and treat skin cancer.
Meet the DermTech Melanoma Test
This simple smart sticker gives your doctor data on your mole’s genomic makeup at the RNA level, showing signs of melanoma earlier and more accurately than a traditional biopsy care pathway.
» See How It Works
In Development
DermTech: Carcinome
Find the presence of non-melanoma skin cancers at the genomic level. The Carcinome test is currently in development.
DermTech: Carcinome
Find the presence of non-melanoma skin cancers at the genomic level. The Carcinome test is currently in development.
DermTech: LuminateSM
Identify UV damage at the genomic level. The LuminateSM test is currently in development.
DermTech: LuminateSM
Identify UV damage at the genomic level. The LuminateSM test is currently in development.
Partners in Innovation
We consult, collaborate and work with leaders in the world of genomics, medicine, biotechnology, wellness, and more.
DermTech in the News
Read how DermTech is changing the world of dermatology.
Make a Difference,
Join the Team
Want to help change the world of dermatology? DermTech is currently hiring for the following positions.